SPECTROPHOTOMETRIC DETERMINATION OF ATORVASTATIN CALCIUM AND PITAVASTATIN CALCIUM THROUGH ION-PAIR COMPLEX FORMATION USING ACID DYES IN PHARMACEUTICAL FORMULATIONS AND HUMAN URINE SAMPLES
DOI:
https://doi.org/10.22159/ijap.2019v11i6.35246Keywords:
Pitavastatin calcium, Atorvastatin calcium, Acid dyes, Spectrophotometry, Ion-pair complex, ValidationAbstract
Objective: The main objective was to develop simple, cost-effective, rapid and selective spectrophotometric methods for the determination of atorvastatin calcium and pitavastatin calcium in pure and pharmaceutical formulations using acid dyes like bromothymol blue, bromocresol purple and bromocresol green and also in human urine samples.
Methods: The developed methods were based on the formation of ion-pair complexes between statin drugs and acid dyes after studying the optimization conditions. The association constants of the developed ion-pair complexes were evaluated using Benesi–Hildebrand equation. The methods were validated according to ICH guidelines.
Results: The formed ion-pair complexes showed maximum absorbance which was measured at 637 nm for both methods A and D, 601 nm, 606 nm for methods B and E and 631 nm for both methods C and F respectively with correlation coefficients 0.999. The analytical parameters and their effects in the developed methods were investigated. The ion-pair complexes were stable up to 24 h and showed good linearity. The molar absorptivity, Sandell sensitivity, detection, and quantification limits were also calculated. The stoichiometry ratio in all the cases was 1:2 by using Job’s method of continuous variation. The recovery studies again showed good results because co-formulated substances did not interfere for the determination of ATC and PTC in the developed methods.
Conclusion: The developed methods were applicable for routine quality control analysis of ATC and PTC in pure and pharmaceutical dosage forms. Good results were obtained when the developed methods were applied in healthy human urine samples.
Downloads
References
Lea AP, McTavish D. Atorvastatin: a review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs 1997;53:828-47.
The United States Pharmacopoeia 37, NF 32. United States Pharmacopoeia Convention, Mack, Easton, PA; 2013. p. 1949.
Indian Pharmacopoeia, Government of India, The Ministry of Health and Family Welfare, the Indian Pharmacopoeia Commission, New Delhi; 2007. p. 749-1574.
Erk N. Extractive spectrophotometric determination of atorvastatin in bulk and pharmaceutical formulations. Anal Lett 2003;36:2699-711.
Frag EYZ, Mohamed GG, Gaber MH. Sensitive extractive spectrophotometric method for the determination of some statin drugs in pharmaceutical preparations. Insight Pharm Sci 2011;1:39-46.
Jadhav SD, Bhatia MS, Thamake SL, Pishawikar SA. Spectrophotometric methods for estimation of atorvastatin calcium form tablet dosage forms. Int J PharmTech Res 2010;2:1948-53.
Al-Adl SM, Abdel Aziz LM, Mohamed MAM. Spectrophotometric determination of atorvastatin calcium and rosuvastatin calcium in bulk and dosage form using p-dimethylaminobenzaldehyde. J Appl Pharm 2017;9:233.
Wani TA, Khalil NY, Abdel Rahman HM, Darwish IA. Novel microwell-based spectrophotometric assay for determination of atorvastatin calcium in its pharmaceutical formulations. Chem Cent J 2011;5:57.
Salwa Fares Rassi. Chemically modified carbon paste ion-selective electrodes for determination of atorvastatin calcium in pharmaceutical preparations. Anal Chem Res 2017;12:65-73.
Ashour S, Bahbouh M, Khateeb M. A novel use of oxidative coupling reactions for determination of some statins (cholesterol-lowering drugs) in pharmaceutical formulations. Spectrochim Acta Part A 2011;78:913-7.
Saradhi SV, Rao GD, Srinivasu P, Venkatesh BSS. Visible spectrophotometric assay for the determination of a lipid lowering drug in pharmaceutical dosage forms. J Pure Appl Microbiol 2007;1:313-5.
Nagaraju P, Pasumarthy, Gopal NV, Srinivas VDN, Padma SVN. Spectrophotometric methods for the determination of atorvastatin calcium in pure and it’s pharmaceutical dosage forms. Asian J Res Chem 2008;1:64-6.
Vamsi krishna M, Gowri Sankar D. Adaptation of color reactions for spectrophotometric determination of pitavastatin calcium in bulk drugs and in pharmaceutical formulations. Eur J Chem 2007;4:272-8.
Bernard S, Mathew M. Spectrophotometric method of estimation of atorvastatin calcium using sulfo-phospho-vanillin reaction. J Appl Pharm Sci 2012;2:150-4.
Ergin G, Caglar C, Onal A, Erturk Toker S. Spectrophotometric determination of 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitors in pharmaceutical preparations. Turk J Chem 2013;37:171-81.
Virupaxappa BS, Shivaprasad KH, Latha MS. Spectrophotometric method for the determination of pitavastatin calcium. Asian J Res Chem 2010;3:643-5.
Virupaxappa BS, Shivaprasad KH, Latha MS. Novel spectrophotometric method for the assay of pitavastatin calcium in pharmaceutical formulations. Chem Sin 2011;2:1-5.
Goud SE, Krishnareddy V, Naresh Chandrareddy M. Development and validation of a reverse-phase liquid chromatographic method for determination of related substances of pitavastatin for 2 and 4 mg tablets. Int J Pharm Pharm Sci 2014;6:95-100.
International Conference on Hormonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1), Complementary Guideline on Methodology, London; 2005.
Published
How to Cite
Issue
Section
